A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer.

Clinical trial NCT07672236 · RECRUITING

Trial details

NCT number: NCT07672236
Sponsor: OncoZenge AB
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Head & Neck Cancer Oral Mucositis

Start date: 2026-07-07
Primary completion: 2026-12-23
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.